Testicular cancer is a form of cancer which develops in the testicles. There may be numerous lumps on the testicles, but, not all of them are malignant or cancerous. Other conditions may include testicular microlithiasis, appendix testis and epididymal cysts. They may be painful but they are not cancerous. This cancer has the highest rates of cure with an average rate of survuival of 95%. If the tumor has not spread to the other parts of the body the survival rate increases to approximately 99%. If in a few cases the cancer has spread to the nearby areas, the condition can be cured by chemotherapy. This offers a cure rate of 80%. The United States diagnose between 7,500 and 8,000 testicular cancer each year. UK diagnoses approximately 2,000 men a year. Over his lifetime, the chances of a man at risk of testicular cancer are roughly 1 in 200. Being the most common form of cancer in males of age group 20–39 years which is the period of peak incidence it is rarely seen before puberty. Online Journals are scholarly and peer reviewed journals. The journals provide forum and motivates scientists, researchers, academics, engineers, and practitioners in all aspects to share their professional and academic knowledge in the fields computing, engineering, humanities, economics, social sciences, management, medical science, and related disciplines. Online Journals also aims to reach a large number of readers worldwide with original and current research work completed on the vital issues of the above important disciplines. The journals permit all readers to read, view, download and print the full-text of all published articles without any subscription or restrictions.Testicular cancer is the most common solid tumor among males 15 to 34 years of age. The age-adjusted annual incidence in the United States is 5.6 cases per 100,000 persons, with a peak of 14.6 cases per 100,000 persons 30 to 34 years of age. Figure 1 includes incidence rates by age and ethnicity.1 In 2017, there were an estimated 8,850 new cases of testicular cancer and 410 deaths. Whites, Hispanics, and American Indian/Alaska Natives have the highest rates of testicular cancer.1 The incidence of testicular cancer has increased over the past several decades for unclear reasons. With effective treatment, the overall five-year survival rate is 97%.2Testicular cancer is a form of cancer which develops in the testicles. There may be numerous lumps on the testicles, but, not all of them are malignant or cancerous. Other conditions may include testicular microlithiasis, appendix testis and epididymal cysts. They may be painful but they are not cancerous. This cancer has the highest rates of cure with an average rate of survuival of 95%. If the tumor has not spread to the other parts of the body the survival rate increases to approximately 99%. If in a few cases the cancer has spread to the nearby areas, the condition can be cured by chemotherapy. This offers a cure rate of 80%. The United States diagnose between 7,500 and 8,000 testicular cancer each year. UK diagnoses approximately 2,000 men a year. Over his lifetime, the chances of a man at risk of testicular cancer are roughly 1 in 200. Being the most common form of cancer in males of age group 20–39 years which is the period of peak incidence it is rarely seen before puberty. Online Journals are scholarly and peer reviewed journals. The journals provide forum and motivates scientists, researchers, academics, engineers, and practitioners in all aspects to share their professional and academic knowledge in the fields computing, engineering, humanities, economics, social sciences, management, medical science, and related disciplines. Online Journals also aims to reach a large number of readers worldwide with original and current research work completed on the vital issues of the above important disciplines. The journals permit all readers to read, view, download and print the full-text of all published articles without any subscription or restrictions.Testicular cancer is the most common solid tumor among males 15 to 34 years of age. The age-adjusted annual incidence in the United States is 5.6 cases per 100,000 persons, with a peak of 14.6 cases per 100,000 persons 30 to 34 years of age. Figure 1 includes incidence rates by age and ethnicity.1 In 2017, there were an estimated 8,850 new cases of testicular cancer and 410 deaths. Whites, Hispanics, and American Indian/Alaska Natives have the highest rates of testicular cancer.1 The incidence of testicular cancer has increased over the past several decades for unclear reasons. With effective treatment, the overall five-year survival rate is 97%.2
Review Article: Journal of Cancer Clinical Trials
Review Article: Journal of Cancer Clinical Trials
Editorial: Journal of Cancer Clinical Trials
Editorial: Journal of Cancer Clinical Trials
Review Article: Journal of Cancer Clinical Trials
Review Article: Journal of Cancer Clinical Trials
Commentary: Journal of Cancer Clinical Trials
Commentary: Journal of Cancer Clinical Trials
Scientific Tracks Abstracts: Journal of Clinical Case Reports
Scientific Tracks Abstracts: Journal of Clinical Case Reports
Scientific Tracks Abstracts: Journal of AIDS & Clinical Research
Scientific Tracks Abstracts: Journal of AIDS & Clinical Research
Scientific Tracks Abstracts: Journal of Advanced Practices in Nursing
Scientific Tracks Abstracts: Journal of Advanced Practices in Nursing
Posters & Accepted Abstracts: Journal of Cosmetology & Trichology
Posters & Accepted Abstracts: Journal of Cosmetology & Trichology
Journal of Cancer Clinical Trials received 95 citations as per Google Scholar report